ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 697859 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 697859; 2) Community: the network communities that were significantly associated with the response to NSC 697859; 3) Molecule: the relationships between components within communities and NSC 697859; 4) MDR: the compounds that were significantly associated with the NSC 697859.

NSC Compound Enrichment Correlation
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0480633950058475 0.46594411
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0480633950058475 0.15345762
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0480633950058475 0.12975135
NSC 752346 Null 0.0480633950058475 0.082480877
NSC 755442 Null 0.0480633950058475 0.026763999
NSC 756401 GW832467X 0.0480633950058475 0.21958554
NSC 758670 TANNIC ACID 0.0480633950058475 -0.16014631
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0480633950058475 0.14003986
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0480633950058475 0.091461594
NSC 105827 SANGIVAMYCIN,-THIO 5.30973832161747e-005 0.12959789
Total:83  Current:82    [First] [Prev] [Next] [Last]